Medication therapy
Showing 9976 - 10000 of >10,000
Locally Advanced (Inoperable) or Metastatic Breast Cancer Trial in Worldwide (Fulvestrant, Capivasertib, Placebo)
Active, not recruiting
- Locally Advanced (Inoperable) or Metastatic Breast Cancer
- Fulvestrant
- +2 more
-
Gilbert, Arizona
- +214 more
Feb 1, 2023
Glioblastoma Multiforme Trial in United States (Nativis Voyager)
Completed
- Glioblastoma Multiforme
- Nativis Voyager
-
Tucson, Arizona
- +6 more
Jan 31, 2023
N/A Healthy Individuals Trial (Myofascial Release, Light Touch Contact)
Not yet recruiting
- N/A Healthy Individuals
- Myofascial Release
- Light Touch Contact
- (no location specified)
Jun 21, 2023
Traumatic Brain Injury, Gait Disorders, Neurologic Trial in Roanoke (HIGT - physical rehab, Low intensity physical therapy)
Recruiting
- Traumatic Brain Injury
- Gait Disorders, Neurologic
- HIGT - physical rehab
- Low intensity physical therapy
-
Roanoke, VirginiaInstitute for Orthopaedics and Neurosciences
Nov 11, 2022
Malignant Female Reproductive System Tumor, Recurrent Cervical Carcinoma, Recurrent Endometrial Carcinoma Trial in Houston
Recruiting
- Malignant Female Reproductive System Neoplasm
- +24 more
- Quality-of-Life Assessment
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Jun 6, 2022
HIV Trial in Cape Town (Doravirine, Dolutegravir)
Not yet recruiting
- HIV
-
Cape Town, South AfricaDesmond Tutu Health Foundation
Nov 18, 2022
Feeding and Eating Disorders Trial in Shanghai (web-based guided self-help Enhanced Cognitive Behavioral therapy, online
Not yet recruiting
- Feeding and Eating Disorders
- web-based guided self-help Enhanced Cognitive Behavioral therapy
- online Enhanced Cognitive Behavioral therapy
-
Shanghai, Shanghai, ChinaShanghai Mental Health Center
May 15, 2023
Perceptions of MDMA-Assisted Therapy Among Veterans With PTSD
Completed
- Post Traumatic Stress Disorder
-
Albany, New YorkStratton VA Medical Center
May 31, 2023
HIV, Mental Health, Illicit Substance Use Trial in Los Angeles, New Orleans (Level 1, Level 2, Level 3)
Active, not recruiting
- HIV
- +3 more
- Level 1
- +2 more
-
Los Angeles, California
- +1 more
Jul 30, 2021
Metabolic Subtypes of Non-Alcoholic Fatty Liver Disease
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Machine Learning
- 10-year ASCVD risk estimation
-
Nanjing, Jiangsu, ChinaDivision of Endocrinology, the Affiliated Drum Tower Hospital of
Sep 29, 2022
Raynaud Phenomenon, Raynaud Disease Trial in Granada (Electrotherapy with Galvanic Current, Control without Electric Stimulation
Completed
- Raynaud Phenomenon
- Raynaud Disease
- Electrotherapy with Galvanic Current
- Control without Electric Stimulation Therapy
-
Granada, SpainUniversity of Granada
Nov 6, 2020
Cervical Cancer, Metastatic Cervical Cancer Trial in Washington, Hackensack (Pembrolizumab, Lenvatinib)
Recruiting
- Cervical Cancer
- Metastatic Cervical Cancer
-
Washington, District of Columbia
- +2 more
Jul 26, 2022
Limited Stage Small Cell Lung Cancer Trial in Guangzhou (Sugemalimab, Placebo)
Not yet recruiting
- Limited Stage Small Cell Lung Cancer
- Sugemalimab
- Placebo
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Nov 12, 2022
ER+ Breast Cancer, HER2-negative Breast Cancer Trial in Christchurch, London, Oxford (Palbociclib 125Mg Tab, Fulvestrant
Recruiting
- ER+ Breast Cancer
- HER2-negative Breast Cancer
- Palbociclib 125Mg Tab
- +5 more
-
Christchurch, United Kingdom
- +3 more
May 19, 2022
Evaluation of Drug's Risk in Pregnant Women
Recruiting
- Pregnancy
- Primary Health Insurance Fund data
- +3 more
-
Toulouse, FranceUniversity Hospital of Toulouse
Aug 26, 2021
Hives Trial in Brooklyn (2% Doxycycline Cream in Generic Aquaphor or Generic Aquaphor)
Active, not recruiting
- Hives
- 2% Doxycycline Cream in Generic Aquaphor or Generic Aquaphor
-
Brooklyn, New YorkSUNY Downstate Medical Center
Oct 13, 2021
Squamous Cell Carcinoma of the Head and Neck Trial in United States (SNS-301, Pembrolizumab)
Terminated
- Squamous Cell Carcinoma of the Head and Neck
-
San Francisco, California
- +9 more
Dec 6, 2022
OCD Trial in Oconomowoc (transcranial direct current stimulation, Sham transcranial direct current stimulation)
Not yet recruiting
- Obsessive-Compulsive Disorder
- transcranial direct current stimulation
- Sham transcranial direct current stimulation
-
Oconomowoc, WisconsinRogers Behavioral Health
Jul 19, 2023
Stroke, Blood Pressure, High Trial in Brooklyn (DESA)
Recruiting
- Stroke
- Blood Pressure, High
- DESA
-
Brooklyn, New YorkUniversity Hospital at Downstate
Nov 2, 2023
Plaque Psoriasis Trial in Houston, Pflugerville (Duobrii 0.01 % / 0.045 % Topical Lotion, CeraVe, Topical Cream)
Recruiting
- Plaque Psoriasis
- Duobrii 0.01 % / 0.045 % Topical Lotion
- CeraVe, Topical Cream
-
Houston, Texas
- +1 more
Mar 8, 2022
Breast Cancer Metastatic, Leptomeningeal Metastasis Trial (Tucatinib Oral Tablet, Capecitabine tablets, Trastuzumab Injection)
Not yet recruiting
- Breast Cancer Metastatic
- Leptomeningeal Metastasis
- Tucatinib Oral Tablet
- +2 more
- (no location specified)
Mar 23, 2023
Keratitis Bacterial, Keratitis Fungal Trial in Linz (Tear Sample Probe)
Recruiting
- Keratitis Bacterial
- Keratitis Fungal
- Tear Sample Probe
-
Linz, Upper Austria, AustriaKepler University Hospital
Nov 16, 2022
COPD (COPD) With Acute Lower Respiratory Infection Trial (Omron C28P nebuliser)
Not yet recruiting
- COPD (Chronic Obstructive Pulmonary Disease) With Acute Lower Respiratory Infection
- Omron C28P nebuliser
- (no location specified)
Sep 25, 2023
Brain Metastases, Nonsmall Cell Lung Cancer Stage III Trial in Winston-Salem (MRI of the Brain, Blood draws, Quality of Life
Not yet recruiting
- Brain Metastases
- Nonsmall Cell Lung Cancer Stage III
- MRI of the Brain
- +2 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Cente
Jan 19, 2023
Metastatic Pancreatic Cancer Trial in Washington (Gemcitabine, Nab paclitaxel, Proglumide Dose level 1)
Not yet recruiting
- Metastatic Pancreatic Cancer
- Gemcitabine
- +3 more
-
Washington, District of ColumbiaLombardi Comprehensive Cancer Center, Georgetown University
Apr 11, 2023